PharmaMar (PHM.MC): analysis and statistics
Return, volatility, Sharpe ratio and risk for PharmaMar, an S&P 500 component in the Health Care sector. Data as of 2026-07-30.
| Last close price | $80.15 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +36.41% |
| Total return over period | +156.65% |
| Annualized volatility | 44.44% |
| Sharpe ratio | 0.74 |
| Sortino ratio | 1.10 |
| Max drawdown | -41.44% |
| CVaR 95% (avg. loss, worst 5% of days) | -5.92% |
| Correlation with the S&P 500 | 0.11 |
| Period range | $25.23 – $102.35 |
| Trading days analyzed | 765 |
Over the last 3.0 years, PharmaMar (PHM.MC) has posted an annualized return of +36.41% with annual volatility of 44.44%, a Sharpe ratio of 0.74. Its worst stretch (max drawdown from a peak) was -41.44%. Its correlation with the S&P 500 is 0.11, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how PHM.MC would fit inside an optimized portfolio alongside other S&P 500 stocks, try the optimizer.
Optimize a portfolio with PHM.MC →
Other Health Care stocks
What is the Sharpe ratio? · How to optimize an S&P 500 portfolio